Inhibition of NR2F6 expression by either shRNA KD or CRISPR-mediated KO inhibited melanoma growth in immune-competent but not immune-incompetent mice, an outcome phenocopied by NACC1 and FKBP10 loss. Here, NACC1 is linked to melanoma.